• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体重指数在急性夏科氏神经关节病中的作用。

Role of body mass index in acute charcot neuroarthropathy.

作者信息

Ross Adrianne J, Mendicino Robert W, Catanzariti Alan R

机构信息

Division of Foot and Ankle Surgery, Western Pennsylvania Hospital, Pittsburgh, PA, USA.

出版信息

J Foot Ankle Surg. 2013 Jan-Feb;52(1):6-8. doi: 10.1053/j.jfas.2012.10.003.

DOI:10.1053/j.jfas.2012.10.003
PMID:23260985
Abstract

Obesity has been posited as a predictor for the development of Charcot neuroarthropathy, a severe form of degenerative joint disease associated with peripheral neuropathy and diabetes mellitus. The present case-control study investigated the relationship between elevated (overweight and obese) body mass index and acute Charcot neuroarthropathy in a diabetic population. The final data set consisted of 49 patients, 20 (40.82%) of whom had Charcot foot and 29 (59.18%) who served as controls. In the present investigation, no statistically significant association was found between an elevated body mass index and the development of acute Charcot neuroarthropathy involving the foot.

摘要

肥胖被认为是夏科氏神经关节病发展的一个预测因素,夏科氏神经关节病是一种与周围神经病变和糖尿病相关的严重退行性关节疾病。本病例对照研究调查了糖尿病患者中升高的(超重和肥胖)体重指数与急性夏科氏神经关节病之间的关系。最终数据集包括49名患者,其中20名(40.82%)患有夏科氏足,29名(59.18%)作为对照。在本研究中,未发现体重指数升高与足部急性夏科氏神经关节病的发展之间存在统计学上的显著关联。

相似文献

1
Role of body mass index in acute charcot neuroarthropathy.体重指数在急性夏科氏神经关节病中的作用。
J Foot Ankle Surg. 2013 Jan-Feb;52(1):6-8. doi: 10.1053/j.jfas.2012.10.003.
2
Measurement of markers of osteoclast and osteoblast activity in patients with acute and chronic diabetic Charcot neuroarthropathy.急性和慢性糖尿病性夏科氏神经关节病患者破骨细胞和成骨细胞活性标志物的测量
Diabet Med. 1997 Jul;14(7):527-31. doi: 10.1002/(SICI)1096-9136(199707)14:7<527::AID-DIA404>3.0.CO;2-Q.
3
Charcot neuroarthropathy: An often overlooked complication of diabetes.夏科氏关节病:糖尿病常被忽视的并发症。
Cleve Clin J Med. 2010 Sep;77(9):593-9. doi: 10.3949/ccjm.77a.09163.
4
Osteoprotegerin gene polymorphism in diabetic Charcot neuroarthropathy.骨保护素基因多态性与糖尿病性夏科氏神经关节病。
Diabet Med. 2012 Jun;29(6):771-5. doi: 10.1111/j.1464-5491.2011.03442.x.
5
The Charcot joint: a modern neurologic perspective.夏科关节:现代神经学视角
J Clin Neuromuscul Dis. 2011 Sep;13(1):1-13. doi: 10.1097/CND.0b013e3181c6f55b.
6
Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial.双膦酸盐治疗夏科氏神经关节病:一项双盲随机对照试验。
Diabetologia. 2001 Nov;44(11):2032-7. doi: 10.1007/s001250100008.
7
Charcot neuroarthropathy in diabetes mellitus.糖尿病性夏科关节病
Diabetologia. 2002 Aug;45(8):1085-96. doi: 10.1007/s00125-002-0885-7. Epub 2002 Jul 11.
8
Risk factors of charcot neuroarthropathy development in patients with type 2 diabetes.2型糖尿病患者发生夏科氏关节病的危险因素。
Exp Clin Endocrinol Diabetes. 2014 Jan;122(1):31-4. doi: 10.1055/s-0033-1358483. Epub 2013 Nov 7.
9
Charcot arthropathy of the foot and ankle associated with rheumatoid arthritis.类风湿关节炎相关的足踝夏科氏关节病。
Foot Ankle Int. 2013 Nov;34(11):1541-7. doi: 10.1177/1071100713500490. Epub 2013 Jul 30.
10
Autoantibodies to post-translationally modified type I and II collagen in Charcot neuroarthropathy in subjects with type 2 diabetes mellitus.2型糖尿病患者夏科氏神经关节病中针对翻译后修饰的I型和II型胶原蛋白的自身抗体。
Diabetes Metab Res Rev. 2017 Feb;33(2). doi: 10.1002/dmrr.2839. Epub 2016 Oct 5.

引用本文的文献

1
Demographic and Clinical Characteristics of Patients With Charcot Neuro-Osteoarthropathy in People With Diabetes Mellitus in Six Countries: A Multicenter Observational Study From 1996 to 2022.六个国家糖尿病患者中夏科氏神经骨关节病患者的人口统计学和临床特征:一项1996年至2022年的多中心观察性研究
J Diabetes Res. 2025 Jan 8;2025:4275741. doi: 10.1155/jdr/4275741. eCollection 2025.